Baolingbao Biology Co Ltd

Baolingbao Biology Co Ltd has a total equity of 2,233,596,070 CNY and a total liabilities of 547,806,460 CNY, resulting in a debt-to-equity ratio of 0.06, which is relatively low. The company's liquidity is assessed as medium, and its current ratio of 1.89 indicates a moderate ability to meet short-term obligations. The company's profitability is reflected in its return on equity of 6.74% and return on assets of 5.42%, which are key metrics for evaluating performance in the food processing industry. These figures suggest that the company is generating a reasonable return on its equity and assets, although a direct comparison to industry medians is not provided in the available data. The company's revenue is concentrated in the food processing segment, and there is no specific information provided on geographic exposure or revenue concentration by region. The company's growth trajectory is not explicitly detailed, but the financial snapshot does not indicate significant changes in revenue or profitability over the most recent period. The risk assessment indicates a low potential for dilution, and the company's liquidity is considered medium. The key flag of net cash being negative after subtracting total debt suggests some liquidity risk, but the overall dilution risk is low. There are no recent events or filings mentioned in the provided data that would significantly impact the company's operations or financial status. The company's capital expenditure of -189,295,470 CNY indicates a reduction in capital spending, which could be a strategic move to preserve cash or a reflection of the company's current financial priorities. The free cash flow of 49,704,600 CNY suggests that the company is generating positive cash flow from operations after accounting for capital expenditures.